文献速递主动脉疾病

高密度新月征并非主动脉瘤破裂先兆的必然征象

The Hyperattenuating Crescent Sign Is Not Necessarily a Sign of Impending Aortic Aneurysm Rupture.
PubMed 文献 · Ann Vasc Surg · 2021-11-14

本研究通过单一医疗系统影像数据库回顾性分析2004至2019年间82例CT显示主动脉瘤伴「新月征」且无明确破裂征象的成人患者,评估孤立新月征与濒临破裂风险的关系。结果显示,择期修复患者就诊至手术间隔6968患者日无急性破裂,无症状且瘤径<6.5cm者经优化合并症后择期干预未见不良结局。

要点

  • 孤立新月征不必然提示濒临主动脉破裂,可能见于快速生长的动脉瘤。
  • 择期修复患者就诊至手术间隔6968患者日,零例急性破裂。
  • 无症状且瘤径<6.5cm、无瘤周脂肪条索等不稳定征象者,优化合并症后择期干预未见不良结局。

核心结论

  • 孤立影像学新月征不伴明确破裂征象(如血胸、主动脉壁破坏、腹膜后出血)不必然是濒临主动脉破裂的指标,但可能见于动脉瘤快速生长时。

研究设计与样本

  • 通过单一医疗系统PACS数据库检索放射学报告发现新月征,纳入2004至2019年间CT显示胸降主动脉、胸腹主动脉或腹主动脉瘤伴新月征的成人患者,排除影像显示明确主动脉破裂征象者,共82例。

主要发现

  • 动脉瘤大小为7.1 ± 2.0 cm。
  • 30例(37%)在本次入院期间行急诊或紧急修复,19例(23%) later行择期修复,33例(40%)因患者选择或禁忌合并症未干预。
  • 未干预患者死亡或失访前中位随访275天。
  • 择期干预患者从就诊至修复间隔6968患者日,零例急性破裂(中位105天)。
  • 择期修复患者动脉瘤小于急诊/紧急修复患者(6.2 ± 1.3 vs. 7.7 ± 2.1 cm,P = 0.008)。

临床怎么用

  • 作者认为,无症状、动脉瘤<6.5 cm且无瘤周脂肪条索等其他不稳定影像征象的患者,可在优化合并症后成功行择期干预,无不良结局证据。
  • 作者指出,应包括其他相关影像学表现、动脉瘤大小和增长速度以及患者症状在内的多种因素指导动脉瘤管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The "crescent sign" is a hyperattenuating crescent-shaped region on CT within the mural thrombus or wall of an aortic aneurysm. Although it has previously been associated with aneurysm instability or impending rupture, the literature is largely based on retrospective analyses of urgently repaired aneurysms. We strove to more rigorously assess the association between an isolated "crescent sign" and risk of impending aortic rupture. METHODS: Patients were identified by querying a single health system PACS database for radiology reports noting a crescent sign. Adult patients with a CT demonstrating a descending thoracic, thoracoabdominal, or abdominal aortic aneurysm and "crescent sign" between 2004 and 2019 were included, with exclusion of those showing definitive signs of aortic rupture on imaging. RESULTS: A total of 82 patients were identified. Aneurysm size was 7.1 ± 2.0 cm. Thirty patients had emergent or urgent repairs during their index admission (37%), 19 had elective repairs at a later date (23%), and 33 patients had no intervention due to either patient choice or prohibitive medical comorbidities (40%). Patients without intervention had a median follow up of 275 days before death or loss to follow up. In patients undergoing elective intervention, 6,968 patient-days elapsed between presentation and repair, with zero episodes of acute rupture (median 105 days). Patients undergoing elective repair had smaller aneurysms compared to those who underwent emergent/urgent repair (6.2 ± 1.3 vs. 7.7 ± 2.1 cm, P = 0.008). No surgical candidate with an aneurysm smaller than 8 cm ruptured. There were 31 patients with previous axial imaging within 2 years prior to presentation with a "crescent sign," with mean aneurysm growth rate of 0.85 ± 0.62 cm per 6 months [median 0.65, range 0-2.6]. Those with aneurysms sized below 5.5 cm displayed decreased aneurysm growth compared to patients with aneurysm's sized 5.5-6.5 cm or patients with aneurysms greater than 6.5 cm (0.12 vs. 0.64 vs. 1.16 cm per 6 months, P= 0.002). CONCLUSIONS: The finding of an isolated radiographic "crescent sign" without other signs of definitive aortic rupture (i.e., hemothorax, aortic wall disruption, retroperitoneal bleeding) is not necessarily an indicator of impending aortic rupture, but may be found in the setting of rapid aneurysm growth. Many factors, including other associated radiographic findings, aneurysm size and growth rate, and patient symptomatology, should guide aneurysm management in these patients. We found that patients with minimal symptoms, aneurysm sizes below 6.5 cm, and no further imaging findings of aneurysm instability, such as periaortic fat stranding, can be successfully managed with elective intervention after optimization of comorbid factors with no evidence of adverse outcomes.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Stoecker JB, Eddinger KC, Pouch AM, et al. The Hyperattenuating Crescent Sign Is Not Necessarily a Sign of Impending Aortic Aneurysm Rupture. Ann Vasc Surg. 2021. PMID: 34788704. doi:10.1016/j.avsg.2021.10.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。